Salarius Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $17 |
Gross Profit | -1 | -1 | 16 | |
EBITDA | -1,005 | -1,466 | -1,770 | -969 |
EBIT | -1,006 | -1,467 | -1,771 | -970 |
Net Income | -972 | -1,424 | -1,715 | -881 |
Net Change In Cash | 0 | 0 | 0 | 17 |
Free Cash Flow | -1,356 | -1,072 | -1,353 | -1,511 |
Cash | 3,284 | 3,272 | 4,373 | 5,899 |
Basic Shares | 1,281 | 600 | 524 | 3,938 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,840 | $5,233 |
Gross Profit | -10 | -6 | 1,821 | 5,226 |
EBITDA | -2 | -31,601 | -12,749 | -7,331 |
EBIT | -12 | -31,607 | -12,768 | -7,349 |
Net Income | -12 | -31,374 | -12,704 | -7,096 |
Net Change In Cash | 0 | 0 | 1,840 | 5,233 |
Cost of Revenue | 7,379 | |||
Free Cash Flow | -12,846 | -19,095 | -10,200 | -10,313 |
Cash | 5,899 | 12,106 | 29,214 | 11,118 |
Basic Shares | 3,264 | 2,124 | 1,654 | 623 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.76 |
2024-06-30 | -$2.37 |
2024-03-31 | -$0.41 |
2023-12-31 | -$0.22 |
